The tight control of viral and host gene expression is critical to the replication of herpesviruses, 18 including the gamma-herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV). While 19 some of the KSHV proteins that contribute to viral and host gene regulation are known, it is clear 20 that there are additional uncharacterized contributing viral factors. Identifying these proteins and 21 their role in gene regulation is important to determine the mechanistic underpinnings of the 22 complex replication cycle of KSHV. Through a reporter-based screen, we have identified several 23 new potential KSHV-encoded gene regulators, including the previously uncharacterized protein 24 ORF42, which we find stimulates global protein production upon overexpression. We have 25 generated an ORF42-null virus, which revealed that ORF42 is required for wild-type levels of 26 virus production. 
complex replication cycle of KSHV. Through a reporter-based screen, we have identified several 23 new potential KSHV-encoded gene regulators, including the previously uncharacterized protein 24 ORF42, which we find stimulates global protein production upon overexpression. We have 25 generated an ORF42-null virus, which revealed that ORF42 is required for wild-type levels of 26 virus production. Moreover, global protein synthesis and the accumulation of viral proteins are 27 reduced in infected cells in the absence of ORF42, suggesting that ORF42 regulates protein 28 synthesis during infection. A comparison of the effects of ORF42 on the levels of RNA and 29 protein suggests that ORF42 acts post-transcriptionally to control protein levels. In addition to 30 gene regulation, ORF42 may have other functions in virion formation, as it is found in viral 31 particles, which is consistent with the described roles of the ORF42 homologs in alpha-and beta-32 herpesviruses. 33 highly regulated fashion in relation to the progression of the replication cycle (5). During latent 69 infection, only a few viral genes are expressed. In contrast, all the KSHV genes are transcribed 70 during the lytic cycle, but their expression occurs in three waves: immediate early, early and late. 71
Immediate early proteins and early proteins control viral and cellular gene expression, viral DNA 72 replication and immune evasion. Late genes are only expressed after viral DNA replication and 73 generally encode proteins involved in virion formation and egress. Our knowledge of the viral 74 factors involved in the regulation of viral protein production and of the cellular mechanisms they 75 usurp is expanding, but remains incomplete. In particular, how post-transcriptional mechanisms 76 contribute to shaping the complex pattern of viral gene expression is largely unknown. 77
To uncover new KSHV factors that regulate host and viral gene expression, we carried out a 78 reporter screen and overexpressed individual KSHV proteins. We examined expression of 79 several reporters with different constitutive promoters and regulatory regions to identify KSHV 80 proteins that have the capacity to broadly affect gene expression. We identified several new 81 KSHV candidate gene regulators, and we characterized the function of one of these proteins, 82 ORF42, in the KSHV replication cycle. KSHV ORF42, which was previously uncharacterized, is 83 one of the core herpesviral proteins. Homologs are present in all herpesvirus subfamilies, 84 although the sequence identity among the subfamilies is limited (less than 20%). Null mutations 85 of the ORF42 homolog UL103 in the beta-herpesvirus human cytomegalovirus (HCMV) and the 86 UL7 homolog in the alpha-herpesviruses pseudorabies virus (PRV) and herpes simplex virus 1 87 (HSV-1) result in a decrease in virus production (6-9). This attenuation is thought to arise from 88 defects in virion formation and potentially directly in viral egress (6, 7). However, there is 89
evidence that UL7 and UL103 may have additional biological activities. One study reported that 90 HSV-1 UL7 may regulate early lytic gene expression during de novo infection (10). Similarly, 91 proteomic analyses of HCMV UL103-associated proteins revealed interaction with several 92 expression. To confirm that the effect of ORF42 was not limited to the reporters we selected, we 143 tested how ORF42 affected global nascent protein production. ORF42-overexpressing cells were 144 treated with the Click-able methionine analogue L-azidohomoalanine (AHA), which is 145 incorporated into nascent proteins. L-AHA was then conjugated to a fluorescent dye and AHA 146 incorporation into newly synthesized proteins was measured by flow cytometry. The median 147 fluorescence intensity of cells transfected with ORF42 was 40% higher than that of cells 148 transfected with empty vector (Fig. 1C) . This result indicates that ORF42 increases global 149 protein synthesis, which is in line with the results of our screen. 150
151
The putative gene regulator ORF42 is a late cytoplasmic protein that is required for wild-152 type levels of virus production 153
The ORF42 locus is predicted to encode a 31-kDa, 278-amino acid protein with homologs in all 154 other herpesviruses. To study ORF42, we engineered a KSHV variant lacking expression of the 155 ORF42 protein, KSHV ΔORF42, by replacing Serine 25 with a stop codon in the KSHV BAC16 156 clone using BAC recombineering ( Fig. 2A) . We chose this mutation because it does not alter the 157 coding sequence of ORF43, which overlaps with the 5' end of the ORF42 coding sequence (Fig.  158 2A). We also made a KSHV BAC16 variant that expresses a C-terminally Flag-tagged version of 159 ORF42 from the viral genome (KSHV ORF42-Flag, Fig. 2B ). Because the transcription 160 termination sequence and a portion of the coding region of ORF41 overlap with ORF42, we 161 duplicated the sequences at the 3' end of ORF42 to preserve expression of ORF41. We generated 162 cell lines latently infected with KSHV WT, ΔORF42 or ORF42-Flag by transfecting the BACs in 163 iSLK.RTA cells, which are uninfected epithelial cells that express a doxycycline-inducible copy 164 of the KSHV master lytic regulator RTA (23). RTA overexpression triggered by doxycycline 165 treatment leads to induction of the KSHV lytic cycle. After transfection, we isolated clonal 166 separate lines infected with wild-type (WT) KSHV. 168 To determine whether ORF42 is required for viral replication, we induced the lytic cycle in WT 169 and ΔORF42 KSHV-infected cells by adding doxycycline, collected supernatant six days after 170 induction and used it to infect naïve HEK293T cells. Because the KSHV BAC16 clone 171 constitutively expresses GFP, the titer of infectious virions produced was measured by counting 172 the percentage of GFP-positive infected HEK293T cells by flow cytometry. We found that cells 173 infected with KSHV ΔORF42 produced significantly fewer infectious virions than WT-infected 174 cells (Fig. 2C , WT = 4.7 *10 4 ± 1.7*10 4 infectious units/mL, ΔORF42 = 8.7 *10 2 ± 6.4*10 2 175 infectious units/mL). To make sure that this defect was due to the ORF42 mutation, we rescued 176 ORF42 in KSHV ΔORF42-infected cells using integrated transgenes that express untagged 177 ORF42, a Flag-tagged version of the protein, or a Flag tag-only empty vector as a negative 178 control. Importantly, rescuing ORF42 in trans allowed us to test the same clonal latently infected 179 line with and without ORF42 expression. We found that ORF42 expression in trans rescued 180 virus production from the ΔORF42-infected cells, which indicates that the defect was indeed 181 caused by the ORF42 mutation (Fig. 2C) . We noticed that untagged ORF42 rescued infectious 182 virus production more efficiently than C-terminally Flag-tagged ORF42. This result suggests that 183 the C-terminal tag may reduce ORF42 activity, similar to what has been reported for the 184 cytomegalovirus ORF42 homolog, UL103 (8). Despite this result, we found that the KSHV 185 ORF42-Flag virus, which expresses ORF42-Flag from the viral genome, still produced at least 186 some infectious virus, as shown by the appearance of GFP-positive cells after exposure to 187 supernatant from KSHV ORF42-Flag infected cells (Fig. 2D) . Nonetheless, because of the result 188 with the ORF42-Flag rescue, we used the KSHV ORF42-Flag infected cells only to examine the 189 spatial and temporal expression of ORF42 (Fig. 2E,F) . Consistent with the annotation of the 190 ORF42 locus, addition of the Flag tag to virus-encoded ORF42 led to the detection of a ~35-40 191 kDa protein (Fig 2E) . Virus-encoded ORF42-Flag was expressed with the kinetics of a late lytic 192 protein. It was not detected during latency, and it appeared at the same time as the late protein 193 ORF26, while the early protein ORF59 was detected earlier (Fig. 2E ). In addition, ORF42 194 production was sensitive to treatment with phosphonoacetic acid (PAA), an inhibitor of viral 195 DNA replication, which is a hallmark of a true late protein (Fig. 2E) . These data agree with 196 results from a previous transcriptome profiling study of KSHV mRNAs in the presence of the 197 viral DNA polymerase inhibitor cidofovir, which indicated that the ORF42 mRNA was not 198 expressed in the absence of viral DNA replication (24). In addition, virus-encoded ORF42-Flag 199 localized almost exclusively to the cytoplasm, as indicated by western blot analysis of 200 fractionated cell lysates (Fig 2F) . This localization was maintained throughout the lytic cycle 201 (data not shown). Collectively, our results show that ORF42 is essential for wild-type levels of 202 viral replication and is a late protein that localizes to the cytoplasm. 203
204

ORF42 regulates global protein production in infected cells 205
In order to test whether ORF42 controls gene expression in infected cells, we again employed the 206 AHA-based metabolic labeling assay to assess the global nascent protein production of KSHV-207 infected cells, specifically ΔORF42-virus infected cells rescued with WT ORF42 or empty 208 vector. The median fluorescence intensity of KSHV lytically-infected cells was 10% lower in the 209 absence of ORF42 (Fig. 2G ). While small, this difference was reproducible and statistically 210 significant (Fig. 2G ). This result indicates that the presence of ORF42 promoted the synthesis of 211 new proteins in infected cells. We note that it is likely that not all KSHV infected cells are 212 lytically reactivating in this assay, and that we may thus be underestimating the effect of ORF42 213 on translation in infected cells. Nevertheless, this small but consistent reduction indicates that 214 ORF42 potentiates the synthesis of a large number of proteins during infection. 215
ORF42 is required for wild-type levels of late viral protein expression 217
Our screen had the potential to identify regulators of both cellular and KSHV gene expression, 218 because we selected several regulatory regions of various origin (Fig. 1A) . Also, the same factors 219 can affect production of both viral and host protein, as seen for example for the ORF37/muSOX 220 protein in the murine gamma-herpesvirus murine gammaherpesvirus 68 (MHV68) (25). To test 221 whether ORF42 can regulate viral genes, we co-expressed ORF42 with an mRNA for KSHV 222 ORF26, which included the coding region and the UTRs from the ORF26 genomic locus. We 223 chose ORF26 because both ORF42 and ORF26 are late proteins, and should thus be expressed at 224 the same time in infected cells. ORF42 co-expression led to an increase in ORF26 protein ( Fig.  225 3A,B), but not mRNA levels (Fig. 3C) . These results indicate that ORF42 can regulate viral 226 proteins and also suggest that ORF42 regulates gene expression post-transcriptionally. We 227 extended these results by measuring the levels of a number of viral proteins at day 4 and 6 post 228 induction. As antibodies against KSHV proteins are limited, the tested proteins were chosen 229 based on the availability of efficient antibodies, rather than specific functions. We observed that 230 mutation of ORF42 reduced the levels of most of the proteins we tested, although the extent of 231 the difference varied (Fig. 4A,B) . Moreover, normal protein levels were restored upon 232 exogenous expression of ORF42, but not by transduction of the empty vector, confirming that 233 the defect was due to ORF42 activity (Fig. 4A,B) . The decrease in protein levels was most 234 pronounced for late proteins, such as the glycoprotein K8.1, the capsid protein ORF26 and the 235 tegument protein ORF33 (Fig. 4B) . In contrast, early proteins were only slightly decreased (Fig.  236   4A ). This is not surprising, since ORF42 is itself a late protein (Fig. 2E) , and early proteins will 237 partially accumulate before ORF42 is expressed. Also, the alteration in late protein levels was 238 not due to a defect in viral DNA replication, because viral DNA replication was not impaired in 239 the ΔORF42 mutant virus (Fig. 4C) . 240 protein production, we measured RNA and protein in parallel for K8.1 and ORF26 (Fig. 5) . 242
While we saw changes in both RNA and protein levels, the changes in protein levels seemed to 243 precede those in RNA levels, at for at least K8.1. At day 4, the changes in RNA levels were not 244 statistically significant (Fig. 5A ) and at day 6, the changes in RNA levels were smaller in 245 magnitude than those in protein levels (Fig. 5B) . These results suggest a non-transcriptional role 246 of ORF42. Also, because transcription of late genes is controlled by a complex of viral 247 transcription factors (5), changes in RNA levels could be indirectly caused by lower levels of 248 these viral proteins. The lack of detectable ORF42 in the nuclear fraction (Fig. 2F ) and the 249 increase in protein but not RNA of an ORF26 reporter upon ORF42 co-expression ( 
ΔORF42-infected cells generate fewer viral particles 255
Although our results suggest that KSHV ORF42 can increase viral and host cell protein 256 production, the main functions ascribed to its alpha-and beta-herpesviral homologs are in virion 257 formation and egress. In particular, some studies have suggested that ORF42 homologs directly 258 regulate egress, because UL7/UL103 mutations reduce the levels of cell-free virus more 259 substantially than cell-associated virus (6, 7). In addition, the ORF42 homologs in alpha-and 260 beta-herpesviruses are components of the tegument (7, 26-29), the layer of proteins between the 261 herpesviral capsid and envelope. This localization is consistent with a role in virion formation, 262 since many proteins involved in virion formation and egress are also tegument components (30). 263
However, whether ORF42 is a tegument protein has remained unclear, since only some of the 264 proteomic studies have detected ORF42 or its gamma-herpesvirus homologs in viral particles 265 also incorporated in virions released into the supernatant. We detected ORF42-Flag in virions 267 isolated by ultracentrifugation, as well as the capsid protein ORF26 (Fig 6A) . It is unlikely that 268 the ORF42 staining is due to cellular debris, because we did not detect the non-virion protein 269 ORF59 in this pellet (Fig. 6A) . We then tested how virion formation and egress were affected by 270 ORF42 mutations. We found that the levels of virion-encapsulated DNA in the supernatant 271 mirrored the relative changes in infectivity. KSHV ΔORF42-infected cells produced fewer viral 272 particles than WT KSHV infected cells, and expression of ORF42 in trans rescued this defect 273 (Fig. 6B ). This result excludes the possibility that KSHV ΔORF42 virions are produced in equal 274 numbers, but are less infectious. Moreover, we reasoned that if KSHV ΔORF42 had a defect in 275 egress, as proposed for UL7 and UL103 (6, 7), there would be little or no ORF42-dependent 276 difference in intracellular infectious virions. To test this idea, we isolated intracellular virus 6 277 days post induction of the lytic cycle using a freeze-thaw method (36) and measured infectious 278 virus levels. We found that the relative levels of extracellular (Fig. 2C) and intracellular ( Fig.  279 6C) infectious virions produced by WT and ΔORF42-infected cell lines as well as the ORF42 280 rescue lines were comparable (Fig. 6C) . Collectively, these results indicate that ORF42 281 contributes to formation of viral particles, although we cannot discern whether this is because it 282 is required for wild-type levels of virion components like ORF26 and K8.1 (Figs. 4, 5 synthesis rates, but the small magnitude of the change suggests it has a somewhat selective 309 effect. Also, based on our results, we conclude that ORF42 acts at a post-transcriptional stage of 310 gene expression. The strongest evidence is that ORF42 overexpression up-regulates the protein 311 levels of an ORF26 reporter without increasing its mRNA levels (Fig. 3 ). In addition, ORF42 is 312 almost exclusively cytoplasmic, while nuclear localization may be expected for a direct effect on 313 transcription (Fig. 2F ). In the context of viral infection, ORF42 mutation decreases viral protein 314 accumulation more dramatically than viral mRNA levels, although we did find that mRNA levels 315 production. It may also be advantageous to boost viral gene expression only in the later stages of 326 the replication cycle, to promote virus formation without exposing the virus to recognition by the 327 immune system too early in replication. Because ORF42 is itself expressed with late kinetics, we 328 favor a model whereby ORF42 has a greater effect on late proteins simply because it is only 329 expressed during late stages of viral replication. However, we cannot exclude the possibility that 330 late protein translation requires specific cellular and/or viral factors like ORF42 that are 331 dispensable for early protein expression, as is the case for late gene transcription. 332
333
While the reduction in virion and tegument protein levels in the absence of ORF42 could explain 334 the reduced viral production, there is a discrepancy in the magnitude of the effect. The change in 335 protein accumulation was less than ten-fold (Figs. 4, 5), while the defect in virus production was 336 at least 50-fold (Fig. 2C ). In addition, ORF42 was found in virions, presumably in the tegument 337 ( have more specific effects on subsets of mRNAs or proteins. For example, ORF45 regulates 356 translation (38), but was not identified in our screen. This is probably due to the fact that ORF45 357 promotes translation predominantly of mRNAs containing highly structured 5' UTRs (43), which 358 was not the case for our reporters. In general, the characterization of the other novel hits from 359 our screen will improve our understanding of how KSHV controls both host and viral gene 360 expression. In addition, further work on ORF42 will elucidate how this protein controls protein 361 production during the late stages of the viral replication cycle. 362
Materials and methods 364
HEK293T cells were cultured at 37°C, 5% CO 2 in Dulbecco's modified Eagle's medium 367 (DMEM, Gibco/Thermo Fisher) supplemented with 10% fetal bovine serum (FBS, Hyclone). 368 iSLK.RTA cells containing wild-type KSHV BAC16, BAC16 ΔORF42, or BAC16 ORF42-Flag 369 were maintained in DMEM supplemented with 10% FBS and 400 μg/ml hygromycin (Enzo 370 Lifesciences). KSHV-infected iSLK.RTA cells that also express a transgene were maintained in 371 DMEM supplemented with 10% FBS, 400 μg/mL hygromycin (Enzo) and 100 μg/mL zeocin 372 (Invivogen). Live cells were imaged using a Nikon eclipse TE2000-u. 373
374
Plasmids 375
The library of Strep-tagged KSHV ORFs in the pCDNA4/TO-C-terminal-Strep backbone (12), 376 pCDNA4/TO-ORF42-Flag (used for cloning ORF42), pCDNA4/TO-C-terminal-Flag, pJP1_Zeo 377 and the TKp-luciferase construct (based on the pGL4.16 vector) were kind gifts by Dr. Britt 378
Glaunsinger. pJP1_Zeo is a modified version of the pLJM-GFP vector in which the puromycin 379 resistance gene was substituted with a zeocin resistance gene. The pBABE-d2GFP construct was 380 created by cloning the d2GFP from the pd2eGFP-N1 construct (Clontech) into the pBABE 381 vector. The hPGKp-DsRedDR construct was created by PCR amplifying the hPGK promoter 382 from the pLJM-GFP vector (Addgene #19319) and cloning it into pCDNA3.1-DsRed-383 destabilized (a kind gift of Chris Sullivan), after excision of the CMV promoter with MluI and 384
BamHI. To express ORF42 from a transgene, ORF42 was PCR amplified from pCDNA4/TO-385 ORF42-Flag with or without the Flag tag, and inserted into the AgeI and EcoRI restriction 386 enzyme sites of the lentiviral vector pJP1_Zeo. To generate pCDNA4/TO-ORF42(untagged), 387 ORF42 amplified from pCDNA4/TO-ORF42-Flag was re-inserted in the PmeI digested 388 pCDNA4/TO-ORF42-Flag vector. pJP1-Flag was generated by excising the GFP gene from 389 pJP1_Zeo, and replacing it with a 3xFlag tag using the restriction sites NheI and EcoRI. To 390 generate the pCMV-ORF26 construct expressing the entire ORF26 mRNA, the ORF26 locus 391 was amplified by PCR from BAC16 and inserted into the backbone of pd2eGFP-N1 digested 392 with Steady-Glo luciferase assay system (Promega). Each ORF was tested twice, and ORFs that 404 increased or decreased luciferase levels were retested a third time. All ORFs that on average 405 increased or decreased luciferase by ≥ 1.5-fold were tested for their effects on GFP expression at 406 least three times. For the GFP assays, protein lysates were collected at 24 hrs post transfection 407 and GFP levels were measured using western blotting, using tubulin as a loading control. A 408
BioRad chemidoc system was used to acquire the Image and the ImageLab software to obtain the 409 quantitations. ORFs that appeared to cause cell death were removed from further analysis. All 410
ORFs that on average increased or decreased GFP protein by ≥ 1.5-fold were tested for their 411 effects on DsRed-DR expression at least three times. For the DsRed assays, protein lysates were 412 collected at 48 hrs post transfection and DsRed levels were measured using western blotting, 413 using actin as a loading control. A Syngene system was used to acquire the Image and the 414 Genetools software to obtain the quantitations. Expression of the ORFs was directly verified 415 during the DsRed testing stage by western blotting, and ORFs that were not expressed well were 416 eliminated from further analysis. 417
418
BAC mutagenesis 419
KSHV BAC16 was kindly provided by Dr. Jae Jung and is described in Brulois et al. (23) . 420
Genetic manipulation of the BAC was performed in GS1783 Escherichia coli, which encodes the 421
Red recombinase and the restriction enzyme I-Sce, using the protocol described by Tischer et al. 
Virion isolation 494
ORF42-Flag KSHV-infected iSLK.RTA cells were plated at a density of 3.06*10 6 cells per dish 495 on six 60-cm 2 dishes. The lytic cycle was induced by addition of doxycycline (1 μg/mL). Six 496 days post-induction the supernatant was collected, and filtered to remove cells and debris. The 497 supernatant was centrifuged at 80,000 x g for 2 hours at 4°C through a 30% sucrose cushion in 498 TNE buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 0.1 mM EDTA). The pelleted virions 499 were resuspended in TNE buffer and underwent a second identical spin. The pelleted virions 500
were then lysed and proteins were isolated using RIPA buffer (50 mM Tris-HCl pH 7.4, 1% NP-501 40, 0.5% Na-deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA). 502
Protein isolation and western blotting 504
Cells were lysed and proteins were isolated using RIPA buffer. Lysates were cleared by 505 centrifugation and total protein concentrations were quantified by Bradford assay (Bio-506 rad). Protein lysates were separated by SDS-PAGE and transferred to PVDF membranes. 507
Membranes were blocked in 5% milk in PBST (PBS with 0.1% Tween-20 (Fisher)) and 508 incubated with primary antibodies for 3 hours at room temperature or overnight at 4°C in PBST 509 with 0.5% milk. Primary antibodies against the following proteins were used: KSHV ORF59, 510 K8.1, ORF68 (all 1:10,000 dilution, gifts from Dr. Britt Glaunsinger (47, 48)) KSHV ORF26, 511 ORF33 and ORF52 (1:1000 dilution with the exception of ORF26, used at 1:5, gifts from Dr. 512
Fanxiu Zhu (42, 49)), KSHV ORF6 (1:500, gift from Dr. John Karijolich and Gary Hayward), 513 Flag (1:500, Sigma), human -actin (1:200, Santa Cruz Biotechnology), human -tubulin 514
(1:1,000, Sigma), GFP (1:1,000, Sigma), DsRed (1:200, Santa Cruz Biotechnology). Secondary 515 Biotechnology) IgG antibodies conjugated to horseradish peroxidase were used at a dilution of 517 1:5000 in PBST with 0.5% milk. Membranes were stained using Pierce ECL western blotting 518 substrate (Thermo Fisher) and imaged with a Syngene G:Box Chemi XT4 gel doc system. 519
Images were quantified using GeneTools version 4.02.03. 520
521
RNA isolation and RT-qPCR 522
Total RNA was extracted using a Quick-RNA MiniPrep kit (Zymo Research) and treated with 523
Turbo DNase (Ambion/Thermo Fisher) before reverse transcription. For reporter mRNA 524 measurements, cDNA was prepared using an iScript cDNA Synthesis Kit (Bio-Rad) per the 525 manufacturer's protocol. For viral mRNA measurements, cDNA was prepared using AMV RT 526 (Promega) per the manufacturer's protocol, using a cocktail of primers targeted at KSHV genes 527 and 18S ribosomal RNA (rRNA), in order to obtain strand-specific measurements. In both cases, 528 human 18S rRNA levels were used as an internal standard to calculate relative mRNA levels. 
Statistical analysis 549
All statistical analysis was performed using GraphPad Prism version 7.0b for Mac OS X, 550 (GraphPad Software, La Jolla California USA After quantitation, expression is reported normalized to actin and relative to WT1 line. All blots shown are from the same biological replicate and are representative of at least 3 biological replicates. Several proteins were measured on the same blot and normalized to the same actin blot, as indicated by the blot number. The band used to quantify K8.1 is marked by the asterisk. (C) Total DNA was collected from cells prior to induction and four days post induction. qPCR was used to measure copy numbers of the viral gene LANA and the cellular gene CCR5. The fold increase in DNA levels after induction was calculated after normalization to CCR5 levels. N ≥ 3. Ns = p > 0.05, relative to KSHV ΔORF42 (ANOVA followed by Dunnet's multiple comparison test). 
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